Biological age predicts dementia and Alzheimer's disease plasma biomarker levels

Abstract

Background: Advancing chronological age is a strong contributor to Alzheimer's disease (AD) risk, yet individual variability exists in aging trajectories. Novel AD biomarkers are needed to better stratify AD risk, especially in preclinical stages.